Rocky Mountain Blood and Marrow Transplant Program

Denver, Colorado 80218

0 studies enrolling now · 9 studies all time

What they study most

Acute Disease, Acute Lymphoblastic Leukemia, Acute Lymphocytic Leukemia, Acute Myelogenous Leukemia, Acute Myeloid Leukemia, Chronic Lymphocytic Leukemia, Chronic Myeloid Leukemia, Graft Failure, Leukemia, Lymphoma, Multiple Myeloma, Myelodysplastic Syndrome

Studies at this site

• Extension Study of Idelalisib in Participants With Chronic Lymphocytic Leukemia (CLL) Who Participated in GS-US-312-0116 (NCT01539512) — Stopped early
• A Randomized, Double-Blind, Placebo-Controlled Study of Idelalisib in Combination With Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL) — Completed
• Study of Voreloxin (Vosaroxin) in Older Patients With Untreated Acute Myeloid Leukemia — Completed
• Phase 2 Study of Carfilzomib in Relapsed Multiple Myeloma — Completed
• A Phase II Controlled Trial of Velafermin for Prevention of Oral Mucositis — Completed
• Fludarabine and 400 CGY Total Body Irradiation for Recipients of HLA-Matched or Mis-Matched Family or Unrelated Donor Hematopoietic Stem Cell Transplants Who Have Rejected Their First Allogeneic Stem Cell Transplant — Status unconfirmed
• Phase III Randomized Study of Amonafide (AS1413) and Cytarabine Versus Daunorubicin and Cytarabine in Patients With Secondary Acute Myeloid Leukemia (AML)- the ACCEDE Study — Status unconfirmed
• Tacrolimus and MMF as Post Grafting Immunosuppression After Conditioning With Flu TBI for HLA Matched Family Donor — Status unconfirmed
• Treatment of Hematologic Malignancies With Single-Unit or Double-Unit Cord Blood Transplantation — Status unconfirmed